Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lol! One of my favorite cartoons!
Go ONCS! Great volume today and going up, up and away!
The skies the limit on this one. IMHO
Once past the second resistance point it will take off and leave those MM's farrrrrrrrr behind.
$ONCS
Thank you GG Gums! I think it worked!
Go ONCS!!
$ONCS
This was copied from Smallcapnetwork.com:
A nice website that tends to deliver news before any other website I have found and is great for articles written by members. Check it out:
What Stock Looks Best-Suited for Annual Gains of 300%?
OncoSec Medical looks well positioned for a great 2014
By Amy Baldwin
Feb 23, 2014 7:37:29 PM PST | 56 View(s) | No Comment(s) - Post a Comment
Biotechnology has been the hottest sector of the market for the better part of two years. It’s true, 300% annual gains have almost become the norm for investors in this space. Though the question remains: what makes for a 300% gain? What are the events that have to play out in order for such gains to become a reality? In answering these questions, let’s first take a look at Inovio Pharmaceuticals (INO), and then shine a light on another company that might see a similar return based on what drove Inovio shares higher in the last 12 months.
What, Why, & How
Inovio Pharmaceuticals is a company focused on the development of synthetic vaccines to treat cancer and infectious diseases. Its synthetic vaccines are then delivered to patients via electroporation, a delivery device that uses electrical currents to give agents a clear pathway to the targeted area. It is this technology that is the epicenter of what makes Inovio both speculative, but also promising.
In 2012, Inovio was a $100 million company with multitudinous products in early development. But, in 2013 it then took off from the mid-$0.50s to its current price, just shy of $3.00. There are three reasons for this breakout in stock performance.
1.Inovio gave the market something unexpected:
Inovio really had three key announcements with its pipeline that took investors by surprise. First, a vaccine developed to prevent H7N9 flu protected 100% of animals that received a lethal dose of the virus. This occurred at a time when deaths caused by this strain were rising rapidly. Inovio also discovered that its electroporation helped to improve the effectiveness of its Pennvax-B HIV vaccine, which helped to validate electroporation as a delivery method. Finally, a preclinical test of a MERS vaccine “induced robust and durable immune response”.
All of the above trials/data were early-stage, but combined gave Inovio investors more reason to be optimistic for the future of electroporation as a way to treat a vast array of diseases.
2.Partnership validates program:
Roche agreed to a partnership on two preclinical candidates with an option for other programs in a deal that could be worth more than $400 million for Inovio. Any partnership is big news for a small biotech, but to partner with a leading research and development company like Roche is a great sign of confidence. This unanticipated event sparked a lot of interest in Inovio.
3.Anticipation of data:
Later this year, Inovio will present Phase II data on a program called VGX-3100 in treating cervical dysplasia. This data will be the most significant to date in terms of patient population. Naturally, Inovio is trading higher in anticipation. Investors are optimistic because of the data already produced.
Which Company Can Repeat History?
In seeking a company that could be the next to produce such gains (and in understanding what drove shares of Inovio higher), OncoSec Medical (ONCS.OB) looks like a solid contender.
Aside from the fact that OncoSec and Inovio both develop electroporation technologies, the catalysts and operations between the two companies are rather alike. Also, OncoSec currently trades with a market capitalization near $100 million, which is the same value Inovio sat at prior to its breakout year.
OncoSec already has robust data in treating melanoma with its ImmunoPulse platform, which is a combination of IL12 and electroporation, along with two other ongoing Phase II trials. According to the company, there will be a new trial in 2014-- and possibly more than one. This brings up the first point of providing something unexpected to the market, which will likely come in the form of treating a new indication with electroporation and an agent besides IL12, most likely an anti-PD1.
OncoSec will more than likely provide some preclinical data to support a larger trial in using electroporation plus an anti-PD1. It is this announcement/data that could cause shares of the company to go sky-high.
Second consideration: OncoSec doesn’t have a partnership with large pharma. But with two announced partnerships in the last year (one being Inovio/Roche), many are expecting OncoSec to be next in line to attract a partner. If so, OncoSec would most certainly trade much higher.
Third, there is the anticipation of Merkel cell carcinoma (MCC) data-- although investors don’t seem too involved in the near-term data in treating MCC. This is an orphan disease; OncoSec is hoping to produce the first FDA approved treatment to fight the cancer.
Currently, OncoSec is treating MCC in an ongoing Phase II trial. The company has already seen IL12 uptake of up to 1,000 fold, meaning electroporation is doing its job to deliver the cancer-fighting agent and allowing the immune system to work its magic. If such data holds, OncoSec could possibly earn an accelerated approval-- or at the very least large stock gains once data is released.
Conclusion
At the end of the day, Inovio traded higher for all the right reasons, driven by data and catalysts. Looking ahead to the next 12 months, OncoSec looks to have the potential for many of those same catalysts. Ergo, if you’re examining catalytic factors for what boosted Inovio’s value, and seeking a company that could produce equal returns with similar catalysts, it seems reasonable to suggest a peer with the same technology that’s positioned in much of the same way as Inovio this time next year. Overall, this insinuates a big year for OncoSec Medical.
There is a nice article on Smallcapnetwork.com regarding ONCS and Inovio. Just not sure how to put it here. Sorry, im technologically challenged. Go ONCS
$ONCS
Not sure if its ok to mention another website on here but I also like to check www.smallcapnetwork.com for latest information and articles on penny stocks. This website tends to post latest news and information about stocks before any other site.
Great recent results from Oncosec and more will be coming soon IMHO! The skies the limit.
$ONCS
Great article on Wall Street Cheat Sheets by Tom Meyer dated December 30, 2013 regarding immunotherapy and Oncosec.
http://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=12j0i3k78/*http://wallstcheatsheet.com/stocks/oncosec-medical-poised-for-exciting-2014.html/?ref=YF
Looks like a great year for Oncosec and its investors IMHO!
$ONCS
Sorry, I jumped the gun! I was expecting to see some news and read an old one! New information should be just around the corner.
$ONCS
Sorry! My bad! Saw it and remarked on it. Still great results.
Results from combination study reported today at 7 A.M.!!! Great results!!
$ONCS
I don't understand the question? I wasn't sure how the prospectus involved ONCS and why it was listed on the page. That's all.
$ONCS
Does anyone know what the prospectus means for ONCS. I didnt see any mention of this stock in the mutual fund prospectus.
$ONCS
Good volume so far. This stock should have a good run today IMO. Lots of anticipation regarding the upcoming results.
$ONCS
Has anyone seen any of the updated information on the studies that were going to be reported during these recent talks. Just wondering. I thought we would have been informed of any new information by now. Still long on ONCS. The skies the limit IMO.
$ONCS
Good post Bababooyah. The company just needs a little exposure for people to realize this companies potential. Well done!
Hopefully it will be sooner rather than later. EIPC will explode IMO as soon as information about its products and partners is released but it is taking so long!
I've been long since 0.19, Just not much to say. I've just been sitting back and waiting for everyone else to realize how much potential this company has. Thought we would have heard more from the company regarding the Melanoma study so far but not worried. All news so far is showing that the company is a diamond in the rough. Bigger and brighter days ahead. Slow and steady wins the race. GLTA!!
Anybody have any information regarding the Sachs Cancer Conference in Boston today?
A buy of 843K! Wish it was me!
EIPC
Just hit 0.01 on Scott. Nice!
EIPC
Great report! Fourth Q in a row of increasing revenue! Plus a buy back of its stock shares. Indicates confidence in itself.
Last buy / ask on Scottrade was 0.013/110K (ask) and 0.0098/10K (bid). Volume is clmbing too.
This is gonna take off soon!
EIPC
Good results to date regarding melanoma study. Unfortunately only 2 patients could be evaluated at 180 days pos tx. As more patient responses to tx are measurable, the company will put the data out for us to see. The company has done a good job at providing information on this site and its own site. I think many potential investors are sitting on fence until additional data becomes available. But so far so good.
With more revenue, they could be in a better position to market the battery technology and the rfid. This could easily snowball into a major company. Two large distributors selling the rfid in u.s.a. and china and talks with battery companies. What's not to like?
Eipc
Yeah, that's what I was trying to do. Good work deep space.
Eipc
10 Great Reasons to consider EIPC!
Just read the latest blog from the company and looks like great reading. Just dont know how to post it here. Anyone with more computer savy than I would be appreciated.
EIPC
Well, you're smarter than I. I sat on the fence and watched it soar before I took the plunge. Well, more like a dip. This is set to takeoff though with a little more good news.
Ino
Just joined the INO party recently. Should have got in earlier but still a very nice ride so far. Feb. 7th report may make this an even better investment. Hoping for the best.
Found out about this stock from researching Oncosec and researched further. This stock just seems to climb and climb so far.
INO
I think the latest Q's should come out this month. Hoping for a fourth consecutive Q of increasing profits. Many customers have had some time to evaluate the RFID's on a small scale and may order more this Q or next. There has also been some mention recently in interest about its battery technology from battery companies. A strong partner with the battery nanotech. will send this stock soaring IMHO.
EIPC
I noticed the remarks in the section you listed which seemed very interesting.
The Company expects to use the remaining net proceeds of the Offering for general corporate purposes, including manufacturing preparations and key tooling and equipment purchase, planned clinical studies, usability and validation testing, sales and marketing channel preparations, promotional and training materials, European operations planning, preparations for ISO certification, implementation of document management software, other research and development expenses, and general and administrative expenses.
Especially the remarks about the manufacturing prep and European operations. Great stuff.
ECTE
Hoping additional MM patient results will be reported soon. That should give this stock the kick start it needs.
ONCS
I was wondering if they were buys but didn't want to open up the can of worms again. Thanks super c. Big things ahead for this company imho. Can't wait for next q to come out. Should be in feb. I think. Expecting better revenues and maybe some more news about battery.
Eipc
Good volume so far and the BID/ ASk is up on scottrade. Go EIPC!
EIPC
Sorry didnt get back to you sooner huggums. It appears that the company has had 3 consecutive q's of increasing revenue. Some of it is due to the federal grant for the battery development and some if from the sales associated with the RFID product. Im not sure about the outstanding class A B stocks. maybe someone else could answer that question better than me. Maybe SuperC. He seems to be the person in the know. I do know that the RFID is a game changer which has increased distance of operation over other RFID's i've seen and the product is being sold in many countries so far with good results for a new product. Go to the website and read about the product for more info. Hope this has helped somewhat and welcome to the group. Big profits ahead IMHO!
EIPC
Great results which will make everyone take notice IMO. These are just confirming the results already published from previous studies. This system is a game changer which is not a backup to traditional systems like the competition. A steal at any price IMO.
ECTE
Nice volume and up 4 cents for the day. Cant complain! Slowly climbing from below a dollar just before the holidays!
Go ECTE!
ECTE
Welcome. Thanks for posting it. Check out the latest blog about the battery technology. Mentions interest from battery companies for its novel nanocoatings. Great read.
EIPC
I read this too. Less expensive, safer and able to handle more chargers. Whats not to love? Between this technology, the nanoplates which are far superior to others on the market and the RFID, I think this company will soon pick up. IMHO.
3 consecutive quarters of ever increasing revenue with a fairly new and game changing technology is very impressive and the batery is not even on the market yet. I feel a partner will soon come on the scene and put this company on the map. Im slowly building up as Im able to. SLOW AND STEADY WINS THE RACE! GO Enable!
EIPC
UP UP AND AWAY WE GO!
This stock is getting noticed and will soar IMO! Will say again that I should have loaded up at $1.00 per share but still a bargain. Lightyears ahead of the nearest competitor in terms of technology and technique.
ECTE
Jumped up 25 percent over the last month with increasing volume. People are starting to notice and its just a matter of time before it gets solid investing momentum behind it. Slow and steady climb so far though. Nice! Wish I bought a ton more when it was a dollar. Never see those prices again imo. But still a great deal at this low price for a game changer.
ecte
Moved around the opening price during the day. Just closed slightly lower at closing. Good volume though.
Eipc posted a photo of its nanocoating for batteries on facebook today. Post states that several battery companies are interested in its technology. Ongoing development of its technology in this area using federal grant money. Not sure how to post the photos on this. The clock on my microwave still blinks 12:00! Curse you technology!